tradingkey.logo

BRIEF-Adverum Biotechnologies Initiates ARTEMIS Phase 3 Study Evaluating Ixo-vec for Wet AMD

ReutersMar 3, 2025 9:54 PM

- Adverum Biotechnologies Inc ADVM.O:

  • ADVERUM BIOTECHNOLOGIES INITIATES ARTEMIS PHASE 3 STUDY EVALUATING IXO-VEC FOR WET AMD

Source text: ID:nGNX835Yyx

Further company coverage: ADVM.O

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

Tradingkey
KeyAI